Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Susan L. Cohn

Concepts (768)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neuroblastoma
187
2020
443
32.130
Why?
Infant
107
2020
2931
3.810
Why?
Child, Preschool
104
2020
3584
3.420
Why?
Osteonectin
9
2016
28
3.370
Why?
Gene Amplification
32
2018
160
3.220
Why?
Neovascularization, Pathologic
16
2011
361
2.840
Why?
Oncogene Proteins
25
2015
70
2.640
Why?
Opsoclonus-Myoclonus Syndrome
4
2020
5
2.590
Why?
Antineoplastic Combined Chemotherapy Protocols
25
2020
2134
2.590
Why?
Child
94
2020
6127
2.490
Why?
Gene Expression Regulation, Neoplastic
32
2019
1144
2.400
Why?
Genes, myc
25
2015
62
2.260
Why?
Nuclear Proteins
28
2015
677
1.990
Why?
Prognosis
63
2020
3418
1.950
Why?
Angiogenesis Inhibitors
7
2011
266
1.880
Why?
Humans
237
2020
75264
1.860
Why?
Schwann Cells
6
2009
38
1.820
Why?
DNA Methylation
8
2019
536
1.620
Why?
Antineoplastic Agents
22
2016
2274
1.530
Why?
Cell Proliferation
11
2019
1516
1.480
Why?
Neoplasm Staging
42
2019
1863
1.480
Why?
Disease-Free Survival
31
2019
1182
1.460
Why?
Female
115
2020
41278
1.370
Why?
Neoplasms, Second Primary
4
2016
222
1.350
Why?
Induction Chemotherapy
4
2020
113
1.340
Why?
Neoplasm Recurrence, Local
16
2019
1088
1.250
Why?
Proto-Oncogene Proteins c-myc
14
2013
119
1.240
Why?
HIV Infections
13
2019
604
1.200
Why?
Oligonucleotide Array Sequence Analysis
4
2016
697
1.200
Why?
3-Iodobenzylguanidine
8
2018
19
1.190
Why?
Immunotherapy
8
2017
454
1.160
Why?
Male
96
2020
38915
1.160
Why?
Adolescent
53
2020
8453
1.150
Why?
Cell Line, Tumor
22
2019
2309
1.150
Why?
Pelvic Neoplasms
3
2014
45
1.140
Why?
Infant, Newborn
28
2020
2249
1.120
Why?
Antibodies, Monoclonal
8
2017
1446
1.100
Why?
Adrenal Gland Neoplasms
9
2017
99
1.080
Why?
Immunoglobulins, Intravenous
3
2020
58
1.070
Why?
African Americans
7
2019
1019
1.030
Why?
Ganglioneuroblastoma
5
2018
6
1.000
Why?
Molecular Targeted Therapy
2
2016
249
0.980
Why?
Neoplasms
13
2019
2361
0.980
Why?
Extracellular Matrix
4
2011
222
0.950
Why?
Neoplasms, Muscle Tissue
1
2020
7
0.930
Why?
Social Stigma
6
2019
50
0.910
Why?
Stromal Cells
4
2009
112
0.900
Why?
Gene Expression Profiling
6
2016
1291
0.890
Why?
5-Methylcytosine
2
2019
85
0.880
Why?
Risk Factors
31
2020
4900
0.870
Why?
Stem Cell Transplantation
9
2019
161
0.860
Why?
Mice, Nude
13
2012
763
0.850
Why?
Epigenomics
1
2019
64
0.850
Why?
Kaplan-Meier Estimate
13
2016
865
0.840
Why?
Naphthyridines
1
2019
29
0.820
Why?
Ploidies
9
2011
45
0.810
Why?
Neoplasm Proteins
7
2020
522
0.800
Why?
Hematopoietic Stem Cell Transplantation
9
2017
722
0.800
Why?
Survival Rate
20
2020
1848
0.780
Why?
Brain Neoplasms
8
2014
760
0.780
Why?
Treatment Outcome
33
2018
7173
0.780
Why?
Decision Support Techniques
1
2019
144
0.770
Why?
Combined Modality Therapy
14
2019
1606
0.770
Why?
Chromosome Aberrations
7
2016
392
0.760
Why?
Cohort Studies
19
2020
2423
0.740
Why?
Neoadjuvant Therapy
1
2019
242
0.740
Why?
Iodine Radioisotopes
5
2015
139
0.730
Why?
Prednisone
1
2017
257
0.720
Why?
Fibroblasts
3
2011
708
0.720
Why?
Medical Oncology
5
2017
285
0.720
Why?
Serum Albumin, Bovine
1
2016
60
0.720
Why?
Follow-Up Studies
20
2020
3623
0.710
Why?
Palmitic Acid
1
2016
36
0.710
Why?
Anti-Retroviral Agents
2
2019
25
0.700
Why?
Tumor Suppressor Proteins
6
2007
270
0.690
Why?
Azacitidine
4
2010
116
0.690
Why?
Tissue Fixation
1
2016
34
0.680
Why?
Formaldehyde
1
2016
45
0.680
Why?
RNA-Binding Proteins
4
2001
212
0.680
Why?
Paraffin Embedding
1
2016
75
0.680
Why?
Isotretinoin
3
2013
21
0.660
Why?
Radiation Injuries
2
2014
159
0.660
Why?
Altruism
1
2015
32
0.650
Why?
Disease Progression
9
2014
1361
0.650
Why?
Age Factors
17
2020
1818
0.650
Why?
Neoplasm Metastasis
10
2019
1000
0.640
Why?
Bone Neoplasms
3
2017
306
0.640
Why?
Lipid Metabolism
1
2016
204
0.630
Why?
Medication Adherence
2
2019
105
0.630
Why?
Risk Assessment
13
2020
2083
0.630
Why?
Protein-Serine-Threonine Kinases
2
2019
529
0.620
Why?
Mice
20
2019
10411
0.620
Why?
Survival Analysis
20
2018
1549
0.620
Why?
Cell Differentiation
13
2015
1406
0.620
Why?
Anti-Inflammatory Agents
1
2017
326
0.620
Why?
Genomics
3
2016
536
0.610
Why?
Genetic Predisposition to Disease
5
2017
2067
0.590
Why?
Soft Tissue Neoplasms
2
2017
129
0.590
Why?
Cell Movement
10
2016
724
0.590
Why?
Tumor Cells, Cultured
19
2007
1084
0.580
Why?
Extracellular Matrix Proteins
2
2011
132
0.540
Why?
Radiotherapy
2
2014
333
0.540
Why?
Social Support
5
2019
182
0.540
Why?
Epigenesis, Genetic
5
2014
379
0.530
Why?
Pediatrics
3
2016
332
0.520
Why?
Adult
40
2020
24067
0.510
Why?
Young Adult
16
2020
5278
0.510
Why?
Animals
26
2019
25729
0.500
Why?
Benzenesulfonates
1
2011
63
0.490
Why?
Microtubule-Associated Proteins
1
2012
183
0.490
Why?
Limbic Encephalitis
1
2011
12
0.490
Why?
Valproic Acid
2
2010
24
0.480
Why?
Molecular Chaperones
1
2011
75
0.480
Why?
Promoter Regions, Genetic
5
2010
910
0.480
Why?
Polymorphism, Single Nucleotide
4
2017
2185
0.480
Why?
Receptor Protein-Tyrosine Kinases
6
2016
159
0.480
Why?
Algorithms
2
2019
1777
0.480
Why?
MAP Kinase Signaling System
1
2011
187
0.470
Why?
Nerve Tissue Proteins
3
2001
510
0.470
Why?
Quinoxalines
1
2011
53
0.470
Why?
Sesquiterpenes
2
2001
13
0.470
Why?
Sulfonamides
5
2013
300
0.460
Why?
United States
13
2019
5681
0.460
Why?
Culture Media, Conditioned
2
2000
102
0.460
Why?
Ganglioneuroma
4
2018
16
0.460
Why?
Pyridines
2
2012
286
0.460
Why?
Gene Silencing
4
2011
178
0.460
Why?
Immunohistochemistry
11
2017
1768
0.450
Why?
Tubulin Modulators
4
2013
27
0.450
Why?
Genes, Tumor Suppressor
6
2007
166
0.440
Why?
Genes, Homeobox
3
1996
88
0.440
Why?
International Cooperation
4
2020
132
0.440
Why?
Xenograft Model Antitumor Assays
6
2012
424
0.430
Why?
Proportional Hazards Models
10
2019
815
0.420
Why?
Radiopharmaceuticals
5
2018
154
0.420
Why?
Salvage Therapy
5
2019
209
0.420
Why?
Neoplasm Transplantation
5
2011
393
0.410
Why?
Health Status Disparities
1
2010
128
0.410
Why?
Thrombospondin 1
2
2010
23
0.410
Why?
Drug Resistance, Neoplasm
9
2019
520
0.400
Why?
Viral Load
4
2019
119
0.400
Why?
L-Lactate Dehydrogenase
4
2020
66
0.400
Why?
Prospective Studies
16
2019
3554
0.400
Why?
Protein Kinase Inhibitors
2
2016
521
0.400
Why?
Stress Disorders, Post-Traumatic
2
2019
59
0.390
Why?
Thoracic Neoplasms
4
2014
61
0.380
Why?
Depression
3
2019
356
0.380
Why?
Tumor Necrosis Factor Decoy Receptors
1
2007
6
0.380
Why?
Oncogenes
5
2006
91
0.380
Why?
Substance-Related Disorders
1
2011
349
0.380
Why?
Caspase 8
1
2007
41
0.380
Why?
Tretinoin
6
2012
121
0.380
Why?
Peripheral Blood Stem Cell Transplantation
4
2013
62
0.380
Why?
Ferritins
3
2020
27
0.370
Why?
Time Factors
10
2019
5246
0.370
Why?
Physical Therapy Specialty
1
2007
2
0.370
Why?
Physical Education and Training
1
2007
4
0.370
Why?
Cell Cycle
5
2011
508
0.370
Why?
European Continental Ancestry Group
1
2012
1028
0.370
Why?
Alcohol Drinking
2
2019
253
0.360
Why?
School Health Services
1
2007
20
0.360
Why?
Clinical Trials, Phase I as Topic
1
2008
150
0.360
Why?
Foreign Medical Graduates
1
2006
6
0.350
Why?
Refugees
1
2006
7
0.350
Why?
Cell Division
7
2003
754
0.350
Why?
Methylation
1
2007
221
0.350
Why?
Ataxia
2
2017
33
0.350
Why?
Recurrence
7
2016
1108
0.340
Why?
Interprofessional Relations
1
2007
105
0.340
Why?
Oligopeptides
1
2007
184
0.330
Why?
Wilms Tumor
5
2004
44
0.330
Why?
Psychiatry
1
2006
74
0.330
Why?
Congenital Abnormalities
1
2005
64
0.330
Why?
Parents
2
2019
226
0.320
Why?
Biomedical Research
3
2017
316
0.320
Why?
Risk
4
2019
675
0.320
Why?
Multidrug Resistance-Associated Proteins
5
2011
31
0.320
Why?
Transfection
6
2011
933
0.310
Why?
Predictive Value of Tests
10
2015
1575
0.310
Why?
Myoclonus
3
1997
14
0.310
Why?
Bone Marrow Neoplasms
2
2017
18
0.300
Why?
Survivors
2
2016
169
0.300
Why?
Research Design
1
2008
537
0.300
Why?
Genome-Wide Association Study
3
2017
1377
0.300
Why?
Genotype
3
2017
1778
0.300
Why?
Radionuclide Imaging
4
2018
235
0.300
Why?
Neurons
2
2005
1550
0.290
Why?
Gangliosides
2
2016
11
0.290
Why?
Adrenal Cortex Hormones
2
2020
239
0.290
Why?
Nervous System Neoplasms
1
2003
16
0.290
Why?
Drug Administration Schedule
3
2019
954
0.290
Why?
Alcoholism
3
2019
163
0.290
Why?
Reverse Transcriptase Polymerase Chain Reaction
9
2009
900
0.280
Why?
Cytokines
1
2007
684
0.280
Why?
RNA, Messenger
11
2016
1944
0.280
Why?
Heat-Shock Proteins
1
2004
166
0.280
Why?
DNA, Neoplasm
8
2004
275
0.280
Why?
Gene Frequency
2
2017
648
0.270
Why?
Laminectomy
2
2001
32
0.270
Why?
Watchful Waiting
2
2013
43
0.270
Why?
Blotting, Southern
7
2004
146
0.270
Why?
Transcriptome
2
2016
393
0.270
Why?
Cyclophosphamide
7
2018
288
0.270
Why?
Lymph Nodes
2
2019
509
0.270
Why?
Polymerase Chain Reaction
6
2011
985
0.260
Why?
Prenatal Exposure Delayed Effects
2
2000
138
0.260
Why?
Abdominal Neoplasms
4
2013
43
0.260
Why?
Ethnic Groups
2
2019
427
0.260
Why?
Peptide Fragments
1
2004
467
0.260
Why?
Case-Control Studies
5
2017
1711
0.250
Why?
Reproducibility of Results
5
2018
2496
0.250
Why?
Apoptosis
4
2019
1729
0.250
Why?
Incidence
7
2016
1498
0.250
Why?
Lymphoma
2
2019
270
0.250
Why?
Topotecan
2
2011
46
0.240
Why?
Microscopy, Fluorescence
3
2011
441
0.240
Why?
Retrospective Studies
13
2017
6416
0.240
Why?
Kidney Neoplasms
4
2006
534
0.240
Why?
Spinal Neoplasms
1
2001
53
0.240
Why?
Fibroblast Growth Factor 2
3
2007
71
0.240
Why?
Diploidy
5
2008
31
0.230
Why?
Cooperative Behavior
2
2015
166
0.230
Why?
Ileal Neoplasms
1
2000
9
0.230
Why?
Duodenal Neoplasms
1
2000
23
0.230
Why?
Neoplasm Invasiveness
3
2012
508
0.230
Why?
Attitude of Health Personnel
1
2006
626
0.230
Why?
Databases, Factual
5
2017
746
0.230
Why?
Endocardial Cushion Defects
1
1999
3
0.220
Why?
Growth Inhibitors
1
1999
47
0.220
Why?
Neovascularization, Physiologic
1
2000
130
0.220
Why?
In Situ Hybridization, Fluorescence
4
2012
351
0.220
Why?
Antibiotics, Antineoplastic
2
1999
128
0.220
Why?
Attitude to Death
1
2019
35
0.220
Why?
Alabama
4
2019
17
0.220
Why?
Cross-Sectional Studies
5
2019
1188
0.220
Why?
Myeloablative Agonists
2
2016
34
0.220
Why?
Mitotic Index
2
2020
11
0.220
Why?
RNA Nucleotidyltransferases
2
1996
13
0.220
Why?
Chromosomes, Human, Pair 1
5
2013
105
0.220
Why?
Antimetabolites, Antineoplastic
2
2016
247
0.210
Why?
Patient Selection
2
2015
654
0.210
Why?
NIH 3T3 Cells
2
2011
103
0.210
Why?
Technetium Tc 99m Medronate
1
1999
12
0.210
Why?
Immunosuppressive Agents
2
2020
1003
0.210
Why?
Clinical Trials, Phase III as Topic
3
2017
144
0.210
Why?
Chromosomes, Human, Pair 2
2
1996
86
0.210
Why?
Spinal Cord Neoplasms
1
1999
50
0.210
Why?
Chromosomes, Human, Pair 11
5
2013
109
0.210
Why?
Loss of Heterozygosity
4
2018
87
0.210
Why?
Pericardium
1
1999
87
0.210
Why?
Substance Abuse, Intravenous
5
2001
48
0.210
Why?
Antineoplastic Agents, Alkylating
3
2016
143
0.210
Why?
Ocular Motility Disorders
2
1997
17
0.210
Why?
Multivariate Analysis
6
2014
993
0.200
Why?
Mitosis
2
2020
144
0.200
Why?
Cell Hypoxia
2
2016
155
0.200
Why?
Religion
1
2019
95
0.200
Why?
RNA
2
2001
481
0.200
Why?
Graft vs Host Disease
1
2000
310
0.200
Why?
Neurologic Examination
2
2017
118
0.200
Why?
Amino Acid Sequence
5
2009
2146
0.200
Why?
Molecular Sequence Data
6
2009
3179
0.200
Why?
Fluorescent Antibody Technique
2
2010
336
0.200
Why?
Transplantation, Heterologous
3
2006
342
0.190
Why?
Receptors, KIR
1
2017
10
0.190
Why?
Neoplasms, Complex and Mixed
1
2017
8
0.190
Why?
DNA-Binding Proteins
4
2014
1152
0.190
Why?
Proto-Oncogene Proteins c-fos
1
1997
63
0.190
Why?
Melphalan
2
2016
83
0.190
Why?
Karyotyping
3
2014
264
0.190
Why?
Transplantation, Autologous
5
2019
276
0.190
Why?
Pheochromocytoma
1
2017
61
0.190
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2000
266
0.190
Why?
Palliative Care
1
2019
236
0.180
Why?
Nurse's Role
1
2017
13
0.180
Why?
Hematopoietic Stem Cell Mobilization
3
2006
44
0.180
Why?
Age of Onset
2
2015
298
0.180
Why?
Pilot Projects
6
2013
733
0.180
Why?
Patient Acceptance of Health Care
1
2019
198
0.180
Why?
Camptothecin
2
2010
196
0.180
Why?
Human Umbilical Vein Endothelial Cells
1
2016
51
0.180
Why?
Databases, Nucleic Acid
1
2016
39
0.180
Why?
Odds Ratio
5
2012
672
0.180
Why?
Gene Expression
4
2000
1280
0.180
Why?
Mutation
4
2016
3567
0.180
Why?
Maintenance Chemotherapy
1
2017
64
0.180
Why?
Buthionine Sulfoximine
1
2016
7
0.180
Why?
RNA, Neoplasm
6
2001
97
0.180
Why?
Dose-Response Relationship, Drug
6
2016
2058
0.180
Why?
Stomach Neoplasms
1
2000
264
0.170
Why?
Professional-Family Relations
1
2016
49
0.170
Why?
Recovery of Function
1
2017
242
0.170
Why?
Smoking
1
2000
547
0.170
Why?
Research Report
2
2013
32
0.170
Why?
Endothelial Cells
2
2010
355
0.170
Why?
Chromosome Deletion
4
2007
231
0.170
Why?
Endothelium, Vascular
3
2004
438
0.170
Why?
Wernicke Encephalopathy
1
2015
5
0.170
Why?
Thiamine
1
2015
8
0.170
Why?
Prescription Fees
1
2015
11
0.170
Why?
Health Education
1
2016
97
0.170
Why?
Fatal Outcome
2
2011
302
0.160
Why?
Head and Neck Neoplasms
4
2014
943
0.160
Why?
Middle Aged
14
2019
23843
0.160
Why?
Patient Advocacy
1
2015
48
0.160
Why?
Positron-Emission Tomography
1
2017
252
0.160
Why?
Down-Regulation
3
2011
499
0.160
Why?
Diffusion of Innovation
1
2015
69
0.160
Why?
Drug Costs
1
2015
51
0.160
Why?
Hydroxamic Acids
1
2015
48
0.160
Why?
Melanoma
1
2019
452
0.160
Why?
Peripheral Nervous System Neoplasms
1
2014
21
0.150
Why?
Lymphatic Metastasis
2
2014
491
0.150
Why?
Acetylation
2
2015
111
0.150
Why?
Proto-Oncogene Proteins
3
2014
650
0.150
Why?
Genetic Association Studies
2
2016
265
0.150
Why?
Adrenocorticotropic Hormone
1
1994
143
0.150
Why?
DNA Copy Number Variations
2
2012
166
0.150
Why?
Radiation-Sensitizing Agents
1
2015
106
0.150
Why?
DNA, Antisense
1
1994
18
0.150
Why?
Chicago
4
2019
1296
0.150
Why?
Up-Regulation
4
2014
671
0.150
Why?
Logistic Models
7
2018
1095
0.150
Why?
Choice Behavior
1
2015
151
0.150
Why?
Orbital Neoplasms
1
2013
15
0.150
Why?
Meningeal Neoplasms
1
1994
49
0.150
Why?
Interdisciplinary Communication
1
2015
131
0.150
Why?
Clinical Trials as Topic
3
2019
1238
0.150
Why?
Antibodies, Monoclonal, Humanized
1
2019
812
0.150
Why?
Socioeconomic Factors
2
2019
526
0.150
Why?
Dura Mater
1
1994
48
0.150
Why?
Disease Models, Animal
3
2011
2126
0.150
Why?
Topoisomerase I Inhibitors
2
2011
37
0.150
Why?
Base Sequence
5
2007
2392
0.150
Why?
SEER Program
1
2014
182
0.150
Why?
Immunomagnetic Separation
1
2013
11
0.150
Why?
Cell Nucleolus
1
2013
22
0.140
Why?
Cell Survival
1
2016
998
0.140
Why?
Pyrazoles
2
2012
149
0.140
Why?
Mediastinal Neoplasms
1
1993
51
0.140
Why?
Retroperitoneal Neoplasms
1
2013
53
0.140
Why?
Patient Participation
1
2015
182
0.140
Why?
Pyrimidines
2
2018
360
0.140
Why?
Computational Biology
1
2016
495
0.140
Why?
Spinal Cord Compression
2
2005
33
0.140
Why?
Receptor, trkA
3
2006
16
0.140
Why?
Interleukin-2
2
2010
279
0.140
Why?
Image Interpretation, Computer-Assisted
1
2018
669
0.140
Why?
Advisory Committees
2
2010
83
0.140
Why?
Anti-HIV Agents
2
2019
105
0.130
Why?
Consensus
4
2018
236
0.130
Why?
Cluster Analysis
1
2014
361
0.130
Why?
Sequence Alignment
2
2009
356
0.130
Why?
Histones
2
2015
278
0.130
Why?
Protein Kinase C
1
1994
298
0.130
Why?
RNA, Viral
2
2011
323
0.130
Why?
Blotting, Western
5
2011
827
0.130
Why?
Phenotype
4
2014
2100
0.130
Why?
Fenretinide
1
2011
3
0.130
Why?
Oncogene Proteins, Fusion
1
2012
113
0.130
Why?
Intracellular Space
1
2011
42
0.130
Why?
Drug Monitoring
3
2018
98
0.130
Why?
Mice, 129 Strain
1
2011
48
0.130
Why?
Severity of Illness Index
1
2017
1643
0.130
Why?
Genes, MDR
3
2006
10
0.130
Why?
DNA Primers
2
2004
568
0.120
Why?
International Classification of Diseases
2
2008
65
0.120
Why?
Models, Statistical
2
2018
562
0.120
Why?
Niacinamide
1
2011
116
0.120
Why?
Phenylurea Compounds
1
2011
103
0.120
Why?
Alcohol-Related Disorders
1
2011
14
0.120
Why?
Leukemia, Myeloid, Acute
1
2016
591
0.120
Why?
Regression Analysis
3
2008
617
0.120
Why?
Extracellular Space
1
2011
105
0.120
Why?
Randomized Controlled Trials as Topic
1
2015
784
0.120
Why?
3' Untranslated Regions
2
2001
87
0.120
Why?
Cyclohexanes
2
2001
14
0.120
Why?
Primary Myelofibrosis
1
1991
52
0.120
Why?
DNA Modification Methylases
1
2010
23
0.120
Why?
Etoposide
4
2018
193
0.120
Why?
Central Nervous System Neoplasms
1
2011
76
0.110
Why?
Transplantation Conditioning
1
2013
332
0.110
Why?
Practice Guidelines as Topic
4
2016
1024
0.110
Why?
Chemotherapy, Adjuvant
1
2012
468
0.110
Why?
Intention to Treat Analysis
3
2019
60
0.110
Why?
HIV
2
2019
41
0.110
Why?
Carboplatin
4
2018
243
0.110
Why?
Cell Shape
1
2010
52
0.110
Why?
Chromatin Immunoprecipitation
1
2010
128
0.110
Why?
Lymphoma, Non-Hodgkin
1
2012
255
0.110
Why?
Dacarbazine
1
2010
109
0.110
Why?
Remission Induction
3
2004
667
0.110
Why?
Histone Deacetylase Inhibitors
1
2010
79
0.110
Why?
Collagen
1
2011
272
0.110
Why?
Protein Transport
1
2011
401
0.110
Why?
Tomography, Emission-Computed, Single-Photon
1
2010
91
0.110
Why?
Pericytes
1
2009
12
0.110
Why?
Sciatic Nerve
1
2009
35
0.110
Why?
Calmodulin-Binding Proteins
1
2009
21
0.110
Why?
Receptors, Cell Surface
2
2009
290
0.110
Why?
HEK293 Cells
1
2011
562
0.110
Why?
Doxorubicin
4
2018
295
0.110
Why?
Tubulin
1
2010
182
0.100
Why?
Transcription, Genetic
3
2003
1132
0.100
Why?
Models, Biological
1
2016
1723
0.100
Why?
Neoplastic Cells, Circulating
1
2009
65
0.100
Why?
Enzyme Inhibitors
2
2010
666
0.100
Why?
Intercellular Signaling Peptides and Proteins
1
2009
173
0.100
Why?
Blotting, Northern
3
1994
273
0.100
Why?
Lung Neoplasms
2
2012
1992
0.100
Why?
Vaginosis, Bacterial
1
2008
10
0.100
Why?
HIV Seronegativity
1
2008
16
0.100
Why?
Ovulation Inhibition
1
2007
2
0.100
Why?
Psychomotor Disorders
1
2008
23
0.100
Why?
Interleukin-8
1
2008
82
0.100
Why?
Interleukin-1beta
1
2008
65
0.100
Why?
Medroxyprogesterone Acetate
1
2007
22
0.100
Why?
Antibodies, Monoclonal, Murine-Derived
1
2008
83
0.100
Why?
Genetic Testing
1
2012
451
0.100
Why?
Renal Insufficiency
1
2008
107
0.100
Why?
Depressive Disorder
2
2019
214
0.100
Why?
Child Behavior Disorders
1
2008
75
0.100
Why?
Neoplastic Stem Cells
1
2009
126
0.100
Why?
Antiretroviral Therapy, Highly Active
1
2007
58
0.090
Why?
Bone Marrow
1
2009
407
0.090
Why?
Contraceptive Agents, Female
1
2007
31
0.090
Why?
Semaphorins
1
2007
16
0.090
Why?
HIV-1
3
2008
154
0.090
Why?
Chromosomes, Human, Pair 3
1
2007
59
0.090
Why?
Leukemia, Lymphoid
1
1987
72
0.090
Why?
CpG Islands
2
2007
132
0.090
Why?
ATP-Binding Cassette Transporters
2
1999
136
0.090
Why?
Tissue Array Analysis
1
2007
120
0.090
Why?
Cell Growth Processes
1
2007
84
0.090
Why?
Cell Transformation, Neoplastic
1
2009
401
0.090
Why?
DNA, Complementary
3
2005
410
0.090
Why?
Interleukin-6
1
2008
220
0.090
Why?
Radiographic Image Enhancement
1
2010
527
0.090
Why?
Bone Diseases, Metabolic
1
1987
29
0.090
Why?
CD4 Lymphocyte Count
3
2019
70
0.090
Why?
State Medicine
1
2006
11
0.090
Why?
Multilingualism
1
2006
13
0.090
Why?
Tissue Preservation
1
2006
16
0.090
Why?
Kidney Diseases
1
1991
416
0.090
Why?
Electrophoresis, Polyacrylamide Gel
2
1996
304
0.090
Why?
Drug Resistance, Multiple
3
2011
30
0.090
Why?
Information Services
1
2006
29
0.090
Why?
Blood Component Removal
1
2006
26
0.090
Why?
Disabled Children
1
2007
43
0.090
Why?
Diagnostic Errors
1
2008
176
0.090
Why?
Peptides
1
2010
613
0.090
Why?
Ultrasonography, Prenatal
2
2000
165
0.090
Why?
Mice, Knockout
1
2011
1822
0.090
Why?
Calcium
1
2011
1198
0.090
Why?
Actins
1
2009
411
0.090
Why?
Capillary Permeability
1
2007
125
0.090
Why?
RNA Helicases
2
1996
36
0.080
Why?
Neoplasm Grading
2
2020
299
0.080
Why?
Evidence-Based Medicine
1
2008
417
0.080
Why?
Patient Education as Topic
2
2019
323
0.080
Why?
GAP-43 Protein
1
2005
7
0.080
Why?
Receptor, Nerve Growth Factor
1
2005
7
0.080
Why?
Cells, Cultured
1
2011
2870
0.080
Why?
Helix-Loop-Helix Motifs
1
2004
24
0.080
Why?
Ki-67 Antigen
1
2005
69
0.080
Why?
S100 Proteins
1
2005
51
0.080
Why?
In Situ Nick-End Labeling
1
2005
126
0.080
Why?
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
1
2004
36
0.080
Why?
HSP47 Heat-Shock Proteins
1
2004
2
0.080
Why?
Interviews as Topic
1
2006
318
0.080
Why?
Health Promotion
1
2007
155
0.080
Why?
Clinical Protocols
1
2005
148
0.080
Why?
Biopsy, Needle
1
2005
268
0.080
Why?
Collagen Type IV
1
2004
25
0.080
Why?
Probability
1
2005
344
0.080
Why?
Membrane Glycoproteins
1
2007
421
0.080
Why?
Antineoplastic Agents, Phytogenic
2
2005
298
0.080
Why?
Carcinoma, Non-Small-Cell Lung
1
2012
872
0.080
Why?
Epidermal Growth Factor
1
2004
121
0.080
Why?
Collagen Type I
1
2004
66
0.070
Why?
Cell Line
4
2007
2556
0.070
Why?
Electrophoretic Mobility Shift Assay
1
2004
75
0.070
Why?
Binding Sites
2
1997
1096
0.070
Why?
Acquired Immunodeficiency Syndrome
2
2002
84
0.070
Why?
Genetic Markers
4
2009
489
0.070
Why?
Conserved Sequence
1
2004
214
0.070
Why?
Diagnosis, Differential
2
2000
1560
0.070
Why?
DNA
1
1990
1274
0.070
Why?
Biopsy
2
2014
1106
0.070
Why?
HLA Antigens
1
2005
222
0.070
Why?
Signal Transduction
3
2012
3242
0.070
Why?
Infant Welfare
1
2003
7
0.070
Why?
Treatment Failure
2
2014
292
0.070
Why?
Transcription Factors
2
2004
1429
0.070
Why?
Capsules
2
2013
53
0.070
Why?
Organ Specificity
2
2000
248
0.070
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
3
2010
106
0.070
Why?
Child Welfare
1
2003
40
0.070
Why?
Protein Folding
1
2004
283
0.070
Why?
Tumor Suppressor Protein p14ARF
1
2001
8
0.060
Why?
Isoenzymes
2
2012
273
0.060
Why?
Protein Structure, Tertiary
1
2004
763
0.060
Why?
Oligonucleotides, Antisense
1
2001
68
0.060
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2001
86
0.060
Why?
Sensitivity and Specificity
3
2009
2037
0.060
Why?
Paresis
1
2001
12
0.060
Why?
Corneal Neovascularization
1
2000
1
0.060
Why?
Health Behavior
2
2001
166
0.060
Why?
Vascular Endothelial Growth Factors
1
2000
59
0.060
Why?
Pesticides
1
2001
25
0.060
Why?
Education, Medical, Continuing
1
2002
92
0.060
Why?
5' Untranslated Regions
1
2000
44
0.060
Why?
Tyrosine 3-Monooxygenase
1
2000
50
0.060
Why?
Paternal Behavior
1
2000
9
0.060
Why?
Endothelial Growth Factors
1
2000
60
0.060
Why?
Kidney
2
2006
1176
0.060
Why?
Chromosomes, Human, Pair 17
2
2012
111
0.060
Why?
Lymphokines
1
2000
114
0.060
Why?
Life Tables
1
2000
53
0.060
Why?
RNA, Small Interfering
2
2014
564
0.060
Why?
Peripheral Nervous System Diseases
1
2001
78
0.060
Why?
Fertility Agents
1
1999
1
0.060
Why?
Maternal Behavior
1
2000
58
0.060
Why?
Polyethylene Terephthalates
1
1999
20
0.060
Why?
Fetal Diseases
1
2000
87
0.060
Why?
Quality Assurance, Health Care
1
2002
221
0.060
Why?
Therapies, Investigational
1
2019
16
0.060
Why?
Quality of Life
2
2019
1155
0.060
Why?
Heart Block
1
1999
41
0.060
Why?
Cytogenetics
1
1999
23
0.050
Why?
Consolidation Chemotherapy
1
2019
20
0.050
Why?
Contraceptives, Oral
1
1999
43
0.050
Why?
Ventricular Outflow Obstruction
1
1999
22
0.050
Why?
Heart Septum
1
1999
45
0.050
Why?
Alleles
2
1994
1074
0.050
Why?
Ventricular Function
1
1999
58
0.050
Why?
Risk-Taking
1
2001
150
0.050
Why?
Hepatomegaly
1
2018
11
0.050
Why?
Myelin P2 Protein
1
1998
1
0.050
Why?
Genetic Techniques
1
1999
75
0.050
Why?
Azepines
1
2018
19
0.050
Why?
Vascular Endothelial Growth Factor A
1
2000
359
0.050
Why?
Systemic Inflammatory Response Syndrome
1
1998
26
0.050
Why?
Killer Cells, Natural
1
2001
287
0.050
Why?
Multiple Organ Failure
1
1998
36
0.050
Why?
Scoliosis
1
1999
70
0.050
Why?
Pregnancy
3
2000
2519
0.050
Why?
Tomography, X-Ray Computed
3
2018
2453
0.050
Why?
Suture Techniques
1
1999
136
0.050
Why?
HIV Seropositivity
2
1996
69
0.050
Why?
Retreatment
1
2018
102
0.050
Why?
Endoscopy, Gastrointestinal
1
2000
167
0.050
Why?
Environmental Exposure
1
2001
250
0.050
Why?
DEAD-box RNA Helicases
2
1996
73
0.050
Why?
Aorta
1
1999
271
0.050
Why?
Health Surveys
1
2019
236
0.050
Why?
Receptors, KIR3DL1
1
2017
1
0.050
Why?
Receptors, KIR2DL1
1
2017
3
0.050
Why?
Prosthesis Implantation
1
1999
120
0.050
Why?
Heart Atria
1
1999
208
0.050
Why?
Mitral Valve Insufficiency
1
1999
154
0.050
Why?
Vanilmandelic Acid
2
1994
6
0.050
Why?
Mitral Valve
1
1999
205
0.050
Why?
Homovanillic Acid
2
1994
34
0.050
Why?
Administration, Oral
2
2011
676
0.050
Why?
Paraneoplastic Syndromes
1
1997
17
0.050
Why?
Aged
4
2019
17078
0.050
Why?
Motivation
1
2019
218
0.050
Why?
Comparative Genomic Hybridization
1
2016
40
0.050
Why?
Thymus Hyperplasia
1
2016
3
0.050
Why?
Rats, Sprague-Dawley
1
2000
1331
0.050
Why?
Magnetic Resonance Imaging
3
2018
2952
0.040
Why?
Genes, DCC
1
1996
2
0.040
Why?
Electrocardiography
1
1999
504
0.040
Why?
Membrane Proteins
2
2000
1140
0.040
Why?
Molecular Weight
1
1996
369
0.040
Why?
Glutamate-Cysteine Ligase
1
2016
7
0.040
Why?
Polymorphism, Restriction Fragment Length
2
1994
164
0.040
Why?
Health Knowledge, Attitudes, Practice
1
2002
479
0.040
Why?
Microsatellite Repeats
1
2016
145
0.040
Why?
Fluorodeoxyglucose F18
1
2017
115
0.040
Why?
Solubility
1
1996
200
0.040
Why?
Ligands
1
2017
400
0.040
Why?
Sequence Analysis, RNA
1
1997
175
0.040
Why?
Emotions
1
2019
261
0.040
Why?
Glutathione
1
2016
106
0.040
Why?
Parent-Child Relations
1
2016
71
0.040
Why?
Clinical Competence
1
2002
641
0.040
Why?
Communication
1
2019
370
0.040
Why?
Cost of Illness
1
2016
141
0.040
Why?
Drug Synergism
1
2016
326
0.040
Why?
Norepinephrine Plasma Membrane Transport Proteins
1
2015
6
0.040
Why?
Alternative Splicing
1
1996
183
0.040
Why?
Gene Deletion
2
2013
328
0.040
Why?
DNA Probes
1
1995
84
0.040
Why?
Age Distribution
2
2010
201
0.040
Why?
Carrier Proteins
1
1998
675
0.040
Why?
DNA Repair
1
2016
331
0.040
Why?
Cyclohexylamines
1
2014
7
0.040
Why?
Echocardiography
1
1999
764
0.040
Why?
Suspensions
1
2013
8
0.040
Why?
Baltimore
4
1996
39
0.040
Why?
Diagnostic Imaging
2
2011
417
0.040
Why?
Response Elements
1
2014
65
0.040
Why?
Genomic Imprinting
1
1994
33
0.040
Why?
Hematopoietic Stem Cells
1
2016
273
0.040
Why?
Graft Survival
1
1998
852
0.040
Why?
Mixed Function Oxygenases
1
2014
65
0.040
Why?
Causality
2
2010
70
0.040
Why?
International Agencies
1
2013
35
0.040
Why?
Quality Control
1
2014
123
0.040
Why?
Decision Making
1
2019
574
0.040
Why?
Heart Ventricles
1
1999
686
0.040
Why?
Aneuploidy
1
1993
58
0.040
Why?
Physician-Patient Relations
1
2019
566
0.040
Why?
Clone Cells
1
1994
297
0.040
Why?
Hematologic Diseases
1
2013
77
0.040
Why?
Japan
2
2010
285
0.040
Why?
T-Lymphocyte Subsets
1
1996
282
0.040
Why?
Chi-Square Distribution
1
2014
384
0.040
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
1994
163
0.040
Why?
Rats
1
2000
4251
0.030
Why?
Gene Library
1
1993
130
0.030
Why?
Cytosine
1
2014
124
0.030
Why?
Developmental Disabilities
1
1994
177
0.030
Why?
Immunoenzyme Techniques
1
2013
330
0.030
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2014
134
0.030
Why?
Nervous System Diseases
1
2013
142
0.030
Why?
Chromosome Mapping
1
1996
1081
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
269
0.030
Why?
Adrenalectomy
1
2012
64
0.030
Why?
Genes, Wilms Tumor
1
1992
7
0.030
Why?
Gastrointestinal Diseases
1
2013
143
0.030
Why?
Hepatitis Antibodies
1
1991
9
0.030
Why?
Homosexuality
1
1991
9
0.030
Why?
Virus Diseases
1
2013
98
0.030
Why?
HIV Seroprevalence
1
1991
13
0.030
Why?
Cloning, Molecular
1
1993
671
0.030
Why?
Thymopentin
1
2011
3
0.030
Why?
Germ Cells
1
2012
92
0.030
Why?
Skin
1
2015
532
0.030
Why?
Translocation, Genetic
1
2012
252
0.030
Why?
Zinc Fingers
1
1991
58
0.030
Why?
Research
1
2012
247
0.030
Why?
Cocaine
1
1991
67
0.030
Why?
Liver Neoplasms
1
2016
581
0.030
Why?
Receptors, Eph Family
2
2000
4
0.030
Why?
Half-Life
1
1990
108
0.030
Why?
Australia
1
2010
79
0.030
Why?
Receptors, Interleukin-2
1
2010
75
0.030
Why?
Immunoblotting
2
2005
280
0.030
Why?
Antibodies
1
2013
363
0.030
Why?
Chromosome Disorders
1
1991
121
0.030
Why?
Receptor, EphB4
2
2000
29
0.030
Why?
Lymphocyte Count
1
2010
95
0.030
Why?
Interphase
1
1990
37
0.030
Why?
Ephrin-B3
2
2000
2
0.030
Why?
Ephrin-B2
2
2000
6
0.030
Why?
North America
1
2010
169
0.030
Why?
Biotransformation
1
2010
55
0.030
Why?
Glucuronides
1
2010
35
0.030
Why?
Models, Genetic
2
2012
909
0.030
Why?
Sulfates
1
2010
60
0.030
Why?
Europe
1
2010
288
0.030
Why?
Canada
2
2001
185
0.030
Why?
Cisplatin
2
2005
553
0.030
Why?
Antibodies, Viral
1
1991
295
0.030
Why?
Homeodomain Proteins
1
1994
519
0.030
Why?
Health Planning Guidelines
1
2009
30
0.030
Why?
Hepatitis C
1
1991
192
0.030
Why?
Cell Adhesion
2
2004
424
0.030
Why?
Mass Spectrometry
1
2010
180
0.030
Why?
Tumor Lysis Syndrome
1
2008
9
0.030
Why?
Salts
1
2008
16
0.030
Why?
Reference Standards
1
2009
108
0.030
Why?
Diuresis
1
2008
35
0.030
Why?
Urate Oxidase
1
2008
12
0.030
Why?
Area Under Curve
1
2010
335
0.030
Why?
Gene Dosage
2
2000
218
0.030
Why?
Patient Care Planning
1
2009
73
0.030
Why?
Specimen Handling
1
2009
90
0.030
Why?
Secretory Leukocyte Peptidase Inhibitor
1
2008
2
0.030
Why?
Vaginal Douching
1
2008
2
0.030
Why?
Vaginal Discharge
1
2008
2
0.030
Why?
Chromatography, High Pressure Liquid
1
2010
317
0.030
Why?
Neoplasm, Residual
1
2009
123
0.020
Why?
Nelfinavir
1
2007
6
0.020
Why?
Nevirapine
1
2007
6
0.020
Why?
Benzoxazines
1
2007
12
0.020
Why?
Injections, Intramuscular
1
2007
64
0.020
Why?
Flow Cytometry
1
1990
710
0.020
Why?
Drug Therapy, Combination
1
2010
950
0.020
Why?
Syndrome
1
1988
420
0.020
Why?
Chromosome Breakage
1
2007
17
0.020
Why?
Vagina
1
2008
97
0.020
Why?
Cardiac Surgical Procedures
1
1991
397
0.020
Why?
Drug Interactions
1
2007
262
0.020
Why?
Maximum Tolerated Dose
1
2008
265
0.020
Why?
Mice, Transgenic
1
2011
1468
0.020
Why?
Radioimmunoassay
1
1987
162
0.020
Why?
Nucleic Acid Hybridization
1
2007
253
0.020
Why?
Safety
1
2007
160
0.020
Why?
Alkaline Phosphatase
1
1987
135
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2008
397
0.020
Why?
Hypercalcemia
1
1987
66
0.020
Why?
Protein Biosynthesis
1
2009
363
0.020
Why?
Phosphorus
1
1987
137
0.020
Why?
Ifosfamide
1
2005
49
0.020
Why?
Genetic Variation
1
2014
1311
0.020
Why?
Mass Screening
1
1991
576
0.020
Why?
Germany
1
2005
64
0.020
Why?
Antigens, CD34
1
2006
151
0.020
Why?
Italy
1
2005
92
0.020
Why?
Parathyroid Hormone
1
1987
232
0.020
Why?
Renal Dialysis
1
2008
357
0.020
Why?
Neutropenia
1
2005
216
0.020
Why?
Thiotepa
1
2004
32
0.020
Why?
Bone Marrow Examination
1
2004
53
0.020
Why?
Breast Neoplasms
1
2018
2569
0.020
Why?
Biological Transport
1
2005
406
0.020
Why?
Cell Nucleus
1
2006
567
0.020
Why?
Analysis of Variance
1
2005
950
0.020
Why?
Cyclin D
1
2001
14
0.020
Why?
Cyclin-Dependent Kinase 6
1
2001
10
0.020
Why?
Cyclin-Dependent Kinase 4
1
2001
20
0.020
Why?
Proto-Oncogene Proteins c-mdm2
1
2001
26
0.020
Why?
Cyclin-Dependent Kinases
1
2001
46
0.020
Why?
Cyclins
1
2001
81
0.020
Why?
Retinoblastoma Protein
1
2001
63
0.020
Why?
Chloramphenicol O-Acetyltransferase
1
2000
30
0.020
Why?
Herpesvirus 4, Human
1
2001
107
0.010
Why?
Clomiphene
1
1999
19
0.010
Why?
Genes, Reporter
1
2000
265
0.010
Why?
Pregnancy Trimester, First
1
1999
58
0.010
Why?
Transcriptional Activation
1
2000
274
0.010
Why?
Tumor Suppressor Protein p53
1
2001
351
0.010
Why?
Referral and Consultation
1
2002
287
0.010
Why?
Fatty Acid-Binding Proteins
1
1998
27
0.010
Why?
Culture Techniques
1
1998
100
0.010
Why?
Mothers
1
1999
116
0.010
Why?
Phosphorylation
1
2001
1124
0.010
Why?
Recombinant Fusion Proteins
1
2000
561
0.010
Why?
RNA, Antisense
1
1997
16
0.010
Why?
Prevalence
2
1991
1116
0.010
Why?
Teniposide
1
1997
7
0.010
Why?
WT1 Proteins
1
1996
17
0.010
Why?
Ischemia
1
1998
232
0.010
Why?
CD4-CD8 Ratio
1
1996
23
0.010
Why?
Codon
1
1996
122
0.010
Why?
Leukemia
1
1998
290
0.010
Why?
Acute Disease
1
1998
821
0.010
Why?
Cell Adhesion Molecules
1
1996
157
0.010
Why?
Critical Care
1
1998
319
0.010
Why?
Sex Distribution
1
1995
167
0.010
Why?
Exons
1
1996
440
0.010
Why?
African Continental Ancestry Group
1
1996
543
0.010
Why?
Intestinal Mucosa
1
1998
848
0.010
Why?
Hepatitis C Antibodies
1
1991
9
0.010
Why?
Intermediate Filaments
1
1991
20
0.010
Why?
Seroepidemiologic Studies
1
1991
47
0.010
Why?
Vimentin
1
1991
45
0.010
Why?
Neural Crest
1
1991
24
0.010
Why?
Nerve Growth Factors
1
1991
67
0.010
Why?
Restriction Mapping
1
1991
171
0.010
Why?
Evaluation Studies as Topic
1
1991
318
0.010
Why?
Polymorphism, Genetic
1
1994
814
0.010
Why?
Sexual Behavior
1
1991
240
0.010
Why?
Aged, 80 and over
1
1998
6121
0.010
Why?
Cohn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_